Lataa...
Targeting oncogenic Notch signaling with SERCA inhibitors
P-type ATPase inhibitors are among the most successful and widely prescribed therapeutics in modern pharmacology. Clinical transition has been safely achieved for H(+)/K(+) ATPase inhibitors such as omeprazole and Na(+)/K(+)-ATPase inhibitors like digoxin. However, this is more challenging for Ca(2+...
Tallennettuna:
| Julkaisussa: | J Hematol Oncol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7789735/ https://ncbi.nlm.nih.gov/pubmed/33407740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-020-01015-9 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|